Has Francesco Gargano, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,152 in general payments to Francesco Gargano, MD across 12 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Francesco Gargano, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Francesco Gargano, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Francesco Gargano, MD

Plastic and Reconstructive Surgery · New York, NYNPI 1831359421

Payments from drug & device makers

$2,152in general payments, 2019–2025

Across 12 payments — averaging $179.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Suvon Surgical LLC$1K
Kerecis Limited$324
Merz North America, Inc.$291
Axogen$154
Derma Sciences, Inc.$122
Misonix Inc$34
plus $27 from 2 others

What the payments were for

Food & beverage$95244%
Education$1,20056%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Suvon Surgical LLC	1	$1,200
Kerecis Limited	2	$324
Merz North America, Inc.	3	$291
Axogen	1	$154
Derma Sciences, Inc.	1	$122
Misonix Inc	2	$34
Smith+Nephew	1	$15
Mentor Worldwide LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,152 in reported general payments places this provider in the 55th percentile of 219 plastic and reconstructive surgery providers in New York.

See all plastic and reconstructive surgery providers in New York →

Medicare billing

Part B allowed, 2024

$37,992

Medicare patients

Services billed

185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	13	$83

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in New York

Babak MehraraNew York$756K
Lawrence BassNew York$341K
Robert GrantNew York$207K
Christine RohdeNew York$180K
Graham SchwarzNew York$125K
Steven LevineNew York$108K
Mark AlbertNew York$105K
Theodore DiktabanNew York$83K
Nicholas BastidasNew York$27K
Philip MillerNew York$24K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →